CRISPR Solutions For Every Milestone

Every successful program begins with reliable, high-quality reagents. During discovery and early development, your focus is on identifying targets, optimizing experimental conditions, validating biological activity, and generating the data needed to advance. Speed, flexibility, and reproducibility are critical at this stage, making research-grade synthetic guide RNAs and CRISPR nucleases an ideal choice for rapid iteration and experimental optimization. As programs evolve, manufacturing needs often expand alongside experimental scope. From exploratory research to larger preclinical studies, access to scalable manufacturing enables teams to generate consistent data while maintaining continuity throughout development. By providing multiple manufacturing scales built on the same synthetic chemistry and quality standards, Synthego helps organizations grow their programs without unnecessary complexity.

As CRISPR programs progress toward Investigational New Drug (IND) submission, expectations around documentation, traceability, and manufacturing controls increase significantly. Materials used during GLP toxicology studies and regulatory submissions must be produced under well-defined quality systems while providing the documentation necessary to support regulatory review. Synthego's INDe portfolio is designed specifically for this critical transition. By combining quality controls with enhanced documentation and manufacturing consistency, INDe materials help bridge the gap between research and GMP production. This enables your team to perform pivotal preclinical studies with confidence while reducing the risk of unexpected manufacturing changes later in development. Working with a single partner throughout development also minimizes technology transfer, simplifies supply chain management, and helps preserve continuity as programs advance toward the clinic.

When it comes to advancing CRISPR-based therapies, Synthego is not just a supplier for an integrated continuum of CRISPR solutions, we are a committed partner with a proven track record in driving innovation and success. By choosing Synthego, you gain access to a comprehensive ecosystem of solutions, technical expertise, and collaborative support, all designed to accelerate your path from early discovery to clinical application. Our partnership approach is rooted in collaboration and transparency. From the outset, Synthego offers hands-on guidance in optimizing your project’s success. Whether it’s selecting the right products, navigating complex regulatory landscapes, or troubleshooting specific challenges, you’ll benefit from our world-class team.